Stay updated on Eribulin + Pembrolizumab in Soft Tissue Sarcomas Clinical Trial

Sign up to get notified when there's something new on the Eribulin + Pembrolizumab in Soft Tissue Sarcomas Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Eribulin + Pembrolizumab in Soft Tissue Sarcomas Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov study record page still displays a 403 Forbidden error. Its footer revision label changes from v3.7.2 to v3.8.0.
    Difference
    0.2%
    Check dated 2026-11-03T20:16:54.000Z thumbnail image
  2. Check
    10 days ago
    No Change Detected
  3. Check
    16 days ago
    Change Detected
    Summary
    A site-wide NIH banner announces a terminology transition from “Artificial Intelligence” to “Super Intelligence,” and the footer revision label changes from v3.7.1 to v3.7.2.
    Difference
    1%
    Check dated 2026-10-20T20:45:54.000Z thumbnail image
  4. Check
    30 days ago
    Change Detected
    Summary
    The footer revision identifier changed from v3.7.0 to v3.7.1 while the page continued to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-06T19:54:51.000Z thumbnail image
  5. Check
    44 days ago
    Change Detected
    Summary
    The page now renders a 403 Forbidden error instead of the study record, indicating access is denied to this entry. The page shows a minimal header, a 403 message, and a Home button.
    Difference
    20%
    Check dated 2026-09-22T23:15:47.000Z thumbnail image
  6. Check
    51 days ago
    Change Detected
    Summary
    A new revision tag v3.7.0 is now shown, replacing the previous v3.6.6, indicating an updated version of the page content.
    Difference
    0.1%
    Check dated 2026-09-15T21:56:44.000Z thumbnail image
  7. Check
    65 days ago
    Change Detected
    Summary
    Revision label updated to v3.6.6, indicating a small backend/content-management update.
    Difference
    0.1%
    Check dated 2026-09-01T21:50:11.000Z thumbnail image

Stay in the know with updates to Eribulin + Pembrolizumab in Soft Tissue Sarcomas Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Eribulin + Pembrolizumab in Soft Tissue Sarcomas Clinical Trial page.